Venture Capital Deals and Investments
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Venture Capital Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
Cassidy Bio Secures $8M Seed Round Led by Ahren Innovation Capital
SeedVenture Capital

Cassidy Bio Secures $8M Seed Round Led by Ahren Innovation Capital

•November 21, 2025
•Nov 21, 2025
0

Participants

Cassidy Bio

Cassidy Bio

company

Lool Ventures

Lool Ventures

investor

10D

10D

investor

AION Labs

AION Labs

investor

Ahren

Ahren

investor

Why It Matters

The funding validates investor confidence in AI‑enabled drug discovery and positions Cassidy Bio to speed up gene‑editing therapy pipelines, potentially reshaping R&D efficiency in the biotech sector.

Deal Summary

Tel Aviv‑based biotech Cassidy Bio announced an $8 million seed round to fund its AI‑driven genomic foundation model for gene‑editing therapies. The round was led by Ahren Innovation Capital with participation from Lool Ventures, 10D VC and AION Lab’s venture seeding track backed by AstraZeneca and Merck KGaA.

0

Comments

Want to join the conversation?

Loading comments...